Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      ANANDA PHARMA LTD (“Ananda” or the “Company”) : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis
      Biotech

      ANANDA PHARMA LTD (“Ananda” or the “Company”) : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis

      March 4, 2026
      Global Implanted Brain-Computer Interface Devices Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight
      Biotech

      Global Implanted Brain-Computer Interface Devices Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight

      March 3, 2026
      Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
      Biotech

      Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

      March 2, 2026
      Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments
      Biotech

      Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments

      March 1, 2026
      Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy
      Biotech

      Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy

      February 28, 2026
      /C O R R E C T I O N — Caris Life Sciences/
      Biotech

      /C O R R E C T I O N — Caris Life Sciences/

      February 27, 2026
      BPC Instruments reports results for 2025
      Biotech

      BPC Instruments reports results for 2025

      February 26, 2026
      Kanazawa University research: Wnt signaling drives stomach cancer spread by reshaping surrounding tissue
      Biotech

      Kanazawa University research: Wnt signaling drives stomach cancer spread by reshaping surrounding tissue

      February 25, 2026
      disAMR Acquires AMR Insights to Build the Leading Global Hub for Antimicrobial Resistance (AMR) Innovation, Investment, and Policy Alignment
      Biotech

      disAMR Acquires AMR Insights to Build the Leading Global Hub for Antimicrobial Resistance (AMR) Innovation, Investment, and Policy Alignment

      February 24, 2026
      CStone Announces MHRA Approval in UK for Sugemalimab in Stage III NSCLC
      Biotech

      CStone Announces MHRA Approval in UK for Sugemalimab in Stage III NSCLC

      February 23, 2026
      « 1 … 3 4 5 6 7 … 138 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026